Cite
MLA Citation
T Ylisaukko-oja et al.. “P629 Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i758–i759. http://access.bl.uk/ark:/81055/vdc_100179844380.0x000018